BioSpace News Archive

Subtle Medical, a healthcare technology company improving the quality and efficiency of medical imaging, announced they are expanding their partnership with Incepto.

Viveon Health Acquisition Corp. announced that VHAQ filed a registration statement on Form S-4 (the “Registration Statement”) with the U.S. Securities and Exchange Commission (“SEC”) on July 13, 2022.

Dr Roffey brings over 20 years of drug discovery experience gained in the pharmaceutical and biotechnology sectors, where he contributed to the development of multiple candidate drugs and late-stage clinical assets. He has extensive experience in a variety of therapeutic areas, including central nervous system, oncology and metabolic disorders across a range of therapeutic modalities.

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), today announced 12-month data from the Phase 1 “Durasert® and Vorolanib in Ophthalmology” (DAVIO) clinical trial evaluating EYP-1901.

Neurophth Therapeutics, Inc., (“Neurophth”) today announced that the Center for Drug Evaluation (CDE) of China National Medical Products Administration (NMPA) has granted a Breakthrough Therapy Designation (BTD) to the Company’s leading gene therapy drug candidate, NR082 (rAAV2-ND4), for the treatment of Leber’s hereditary optic neuropathy (LHON) associated with mtND4 mutation.

ImpediMed Limited (ASX: IPD) is pleased to announce that two abstracts evaluating use of ImpediMed’s SOZO® Digital Health Platform in heart failure patients were accepted for poster presentation at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2022 taking place from September 30 to October 3 in Washington D.C.

Cancer Vaccine Market Expected To Surpass USD 15 Billion As Per Recent Report Published By Kuick Research.

Alzheimer disease is a neurodegenerative disorder which is characterized by significant cognitive deficits, behavioral changes, sleep disorders, and loss of functional autonomy.

Parkinson’s disease is a most commonly diagnosed age related neurodegenerative disorder, which affects the normal movements of body due to genetic and environmental factors.

The financial report is posted on SEDAR. Paul Blunden, M.D., President CVR Medical Corp., acknowledges the quality work put in by the Audit Committee to complete the 2021 Audit.